28 Mar 2024
Take part in research to improve our online services
Can you help us continue to improve our website and online services?
23 Feb 2024
Breast cancer cannot wait: Open letter regarding inadequate access to diagnostic imaging in Tasmania for breast cancer
Breast Cancer Network Australia (BCNA) remains deeply concerned about the lack of access to diagnostic imaging in the public system in the south of Tasmania and calls on all candidates contesting the 2024.
07 Feb 2024
BCNA welcomes new Peta Murphy Breast Imaging Suite at Frankston Hospital
Thousands of people in Frankston and broader Mornington Peninsula communities will have access to comprehensive public diagnostic breast imaging at the new Peta Murphy Breast Imaging Suite at Frankston Hospital.
05 Feb 2024
Counting people with metastatic breast cancer: a step closer
A roadmap to finally count the number of people diagnosed with incurable and life limiting metastatic breast cancer (MBC) is a step closer thanks to the $1.5 million announced Prime Minister Anthony Albanese to fund a cancer data alliance on Saturday 3 February.
19 Dec 2023
BCNA welcomes decision to recommend two crucial breast cancer drugs for government subsidy
Breast Cancer Network Australia (BCNA) has welcomed a decision by the Pharmaceutical Benefits Advisory Committee (PBAC) to recommend two crucial drugs to treat early breast cancer for a government subsidy.
04 Dec 2023
Vale Peta Murphy MP
It is with much sadness that Breast Cancer Network Australia (BCNA) acknowledges the death of Peta Murphy MP.
29 Nov 2023
Time to Count People with Metastatic Breast Cancer
Finding a way to have people living with metastatic breast cancer consistently counted on our cancer registries is a step closer to reality.
16 Nov 2023
Appointment of new BCNA Board members
At BCNA's Annual General Meeting today, Surgical Oncologist Professor Bruce Mann retired from the Board after 9 years' service. We are so grateful to Bruce for his commitment and passion for BCNA and our purpose. We know he will continue to remain a friend of BCNA.
09 Nov 2023
Enhertu approved for PBS for those with HER2 metastatic breast cancer
BCNA welcomes the listing of Enhertu (trastuzumab deruxtecan) on the Pharmaceutical Benefits Scheme (PBS) for those with metastatic breast cancer
02 Nov 2023
The power of BCNA’s consumer voice at COSA
BCNA’s internationally recognised Seat at the Table (SATT) program helps ensure that consumer voice is central in achieving better care, treatment and support for those affected by breast cancer.